Suzhou Zelgen Biopharmaceuticals News and Activities

Suzhou Zelgen Biopharmaceuticals is one of the...

• CSI 500;
• TOB Iconic 10,000.

Suzhou Zelgen Biopharmaceuticals is a company listed under the stock ticker 688266 (CL).

View the org chart displaying its 2 main executives

Most searched biographies at Suzhou Zelgen Biopharmaceuticals

• Zelin Sheng, Chairman and General Manager
• Jisheng Wu, Deputy General Manager

Create your alert
to follow the executive moves at Suzhou Zelgen Biopharmaceuticals.

Suzhou Zelgen Biopharmaceuticals has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Corden Pharma has announced the acquisition of AmbioPharm  (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Suzhou Zelgen Biopharmaceuticals

Social media about Suzhou Zelgen Biopharmaceuticals

• Suzhou Zelgen Biopharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Suzhou Zelgen Biopharmaceuticals on LinkedIn, X (Twitter) & YouTube